investingreview.org logo
Vermeiden Sie Betrug, informieren Sie sich und finden Sie das Beste
Nothings Found.

Examining ACON Equity Management's Q3 vs. Q4 2022 Holdings: Notable Changes in Funko, Codexis, and Bluebird Bio Shares.

Ava Hoppe | 19 April, 2023

As we move towards the end of the year, it's time to take stock of the various changes that have taken place in the financial world. One particularly interesting data set to examine is the Q3 2022 vs. Q4 2022 13F Holdings Comparison for ACON Equity Management, L.L.C. The data provides insight into the holdings of the firm, and how they have changed over the course of the year.

At first glance, one of the standout changes in holdings is for Funko, Inc. The data shows that ACON Equity Management held 1,802,023 shares of the company in both Q3 and Q4 of 2022. However, the value of these shares saw a significant drop, falling from $36,437,000 in Q3 to just $19,660,000 in Q4 - a decrease of 46%.

So, what happened to Funko, Inc. to cause such a sharp drop in value? A little bit of research reveals that the company's stock price fell consistently throughout the quarter, dropping from a high of $23.82 in early September to a low of $9.62 in late December - a decrease of almost 60%. The company's financials didn't fare much better, with Q3 revenue falling by over 30% compared to the same quarter in the previous year.

It's worth noting that the decrease in value of Funko, Inc. wasn't the only change in holdings for ACON Equity Management. The data shows that the firm made a number of other alterations to their holdings throughout the year, with some positions being trimmed while others were increased.

For example, ACORN Equity Management increased their holdings in Codexis, Inc. by over 3 million shares, going from over 4 million shares in Q3 to nearly 8 million in Q4. The value of these shares also increased significantly, going from $53,954,000 in Q3 to $163,328,000 in Q4 - an increase of over 200%.

Other notable changes in holdings include a significant decrease in shares of Bluebird Bio, Inc., which dropped from 2,740,469 in Q3 to just 238,200 in Q4. The value of these shares also saw a sharp decline, going from $303,949,000 in Q3 to just $26,223,000 in Q4.

Overall, the Q3 2022 vs. Q4 2022 13F Holdings Comparison for ACON Equity Management, L.L.C. shows that the firm made some significant moves throughout the year. While some of these changes resulted in significant gains, others resulted in significant losses. The data provides a valuable look into the world of financial investments and the ever-changing nature of the market.

Viele Menschen wurden durch Betrug und Ponzi-Vorhaben verbrannt. Deshalb haben wir diese Website erstellt, um Ihnen als potenziellem Investor dabei zu helfen, die Fakten zu ermitteln, die besten zu finden und Betrugs- und Ponzi-Vorhaben zu vermeiden.

Alle auf dieser Website bereitgestellten Informationen werden ohne Gewähr und nur zu Informationszwecken bereitgestellt.
InvestingReview.org bietet keine Anlageberatung an. InvestingReview.org ist kein Anlageberater und wird von keiner US-amerikanischen oder nicht US-amerikanischen Aufsichtsbehörde unterstützt oder ist mit dieser verbunden.


Kürzlich gesuchte Firmen

Bitte beachten Sie: Die Suchdaten werden von Dritten gesammelt und einmal täglich aktualisiert.

Copyright © 2023 by InvestingReview.org / Alle Rechte vorbehalten.